about
Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active siteThe Role of Protein-Protein and Protein-Membrane Interactions on P450 FunctionEffective manipulation of the electronic effects and its influence on the emission of 5-substituted tris(8-quinolinolate) aluminum(III) complexesAdministration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in ratsHarnessing a ratiometric fluorescence output from a sensor array.Encapsulated energy-transfer cassettes with extremely well resolved fluorescent outputs.Polymer nanofibre junctions of attolitre volume serve as zeptomole-scale chemical reactors.The largest 15N-15N coupling constant across an NHN hydrogen bond.Human gut microbiota plays a role in the metabolism of drugs.What common structural features and variations of mammalian P450s are known to date?Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T.Effects of anthocyanins on the AhR-CYP1A1 signaling pathway in human hepatocytes and human cancer cell lines.Phase II drug metabolizing enzymes.Hydrophilic polymer matrices in optical array sensing.Is there a relationship between the substrate preferences and structural flexibility of cytochromes P450?Cardiovascular effects of coumarins besides their antioxidant activity.Effects of obesity on liver cytochromes P450 in various animal models.Multianalyte sensing of addictive over-the-counter (OTC) drugs.Enzyme systems of detoxication - overview of recent approaches.1-(4-Chloro-phen-yl)-3-(2-meth-oxy-anilino)propan-1-one.Acyclic nucleoside phosphonates: a study on cytochrome P450 gene expression.8-Meth-oxy-4-(4-methoxy-phen-yl)quinoline.Influence of probiotics on rat liver biotransformation enzymes.Porcine CYP2A19, CYP2E1 and CYP1A2 forms are responsible for skatole biotransformation in the reconstituted system.Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences.Modulation of porphyrin binding to serum albumin by pH.Red-green-blue emission from tris(5-aryl-8-quinolinolate)Al(III) complexes.Minipig as a model for drug metabolism in man: comparison of in vitro and in vivo metabolism of propafenone.Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs.Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1.Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 in vitro."Turn-on" fluorescent sensor array for basic amino acids in water.Interaction of antitumor platinum complexes with human liver microsomal cytochromes P450.Interactions of olomoucine II with human liver microsomal cytochromes P450.Ultrafast energy transfer in oligofluorene-aluminum bis(8-hydroxyquinoline)acetylacetone coordination polymers.Interspecies comparison of the glucuronidation processes in the man, monkey, pig, dog and rat.Minipig cytochrome P450 2E1: comparison with human enzyme.Rational design of a minimal size sensor array for metal ion detection.Sensing of antipyretic carboxylates by simple chromogenic calix[4]pyrroles.
P50
Q24609983-D68C4EA8-4FBC-4DDF-B98B-34B51CF393C3Q27345454-B042EF70-9EEA-440B-B80F-25B99C24BDA1Q28235114-0E65424B-8E28-49B7-A0E2-8FC004EBF7E6Q28539513-6D9E7F61-091E-401B-BC4F-85DE86564D66Q33358725-E260293B-8900-4891-B3BE-BF832EBA1339Q33755276-099A0BE7-3770-4EE9-819E-CE7BB59C06D6Q33838151-82A82C6D-0C2F-43AB-8998-2AFC1F1744DBQ34468766-D921DDD2-A747-49B2-AC2F-B1F09C11A507Q36093162-EAD4B0F4-5E3F-44DE-88AF-0339B0A1A1BDQ36636833-B05539C1-B608-48B0-848F-1ACE662F60EEQ36815972-83805EB1-9BB3-4B04-AA3D-A2330C19C365Q37137662-18B53F55-D476-4A8E-9963-5317D1B04642Q37776407-8DAF3281-8EB4-4469-8CFF-62F0CC545B9AQ37785383-34FE2D92-D4B1-4D8A-A9C5-FE91E2B064B9Q37972328-565A90BA-934C-486E-A24B-C4252C1A40E4Q38362033-9FC8205C-A90A-4DA0-A424-D3229B1804D4Q39331449-44EAF90E-6AFF-4370-AE97-60EEA8784EF7Q39356571-B8B62360-91EB-46BA-A5D1-A5DC9A7C1D1FQ41451881-0A4FEBDD-AF91-4066-BC06-A538C2FB26A7Q42092661-2F19E079-FCAC-4FC7-A044-A7724BDFD194Q42233845-565678F1-30E6-4C01-B571-4CB94C09B8D0Q42366323-4CC608C2-BF2D-4888-85FC-F789C620D582Q43212170-8F848A59-3003-47CF-A4D1-E300DF5E625FQ43212172-EB491F7B-9F46-41D6-AE22-A481C94F772CQ44492038-9A1E784A-72E1-48B1-B69C-239045AE8E59Q44732328-19499D04-9895-41C5-948B-23E0B4588256Q44778490-8AC4D75F-2326-422C-B17A-3A0D9F408A58Q44810306-4E9524AE-4637-424F-86FB-02DC3CA685C3Q44904693-C24BD8A2-EABA-4E51-A393-8F16A7E0612BQ45065966-7A737316-0912-4002-ABFE-D9EFC9E05F5FQ45283948-FB89BF5A-FC00-4083-9C2B-1DAA7590BB19Q45962183-BB05303B-0BFB-4266-8A85-9C6CE4B26ADDQ46007528-A2C046B3-F529-43D3-8F39-63F96AF934E3Q46044984-D34E37D0-5396-408E-AD47-796A9F9D9C0FQ46104709-2BF48232-D122-46BC-83C5-6C9A02069606Q46161613-8982A203-B80F-45E6-B51F-E6AE7B833620Q46261891-0F3B35D8-48F6-4B49-A12A-1CEB2C13A256Q46390993-018D1978-2651-423A-8DAB-477E70AEF892Q46491612-F84F036B-4C22-4804-96DD-3C44C3508A16Q46532452-BD7DBE6C-676A-4C36-8F06-2CA610E5F12D
P50
name
Pavel Anzenbacher
@ast
Pavel Anzenbacher
@en
Pavel Anzenbacher
@nl
type
label
Pavel Anzenbacher
@ast
Pavel Anzenbacher
@en
Pavel Anzenbacher
@nl
prefLabel
Pavel Anzenbacher
@ast
Pavel Anzenbacher
@en
Pavel Anzenbacher
@nl
P1006
P214
P1006
P214
P31
P569
1947-01-01T00:00:00Z
P7859
lccn-n85329983